Author: digi

Participant Compensation in Clinical Trials: Ethics, Regulations and Local Laws

Posted on By digi

Participant Compensation in Clinical Trials: Ethics, Regulations and Local Laws Participant Compensation in Clinical Trials: Ethics, Regulations and Local Laws Clinical trials are fundamental to advancing medical knowledge, validating new therapies, and ensuring safety and efficacy. An important aspect of clinical trials is the ethical and regulatory handling of participant compensation. This guide provides a…

Read More “Participant Compensation in Clinical Trials: Ethics, Regulations and Local Laws” »

Compensation, Reimbursement & Undue Influence

Auditing Participant Compensation Records for Compliance and Fairness

Posted on By digi

Auditing Participant Compensation Records for Compliance and Fairness Auditing Participant Compensation Records for Compliance and Fairness In the constantly evolving landscape of clinical research, ensuring compliance and fairness in participant compensation is paramount. The integrity of clinical trials, particularly those conducted at a clinical trial center, hinges on transparent and equitable compensation practices. This article…

Read More “Auditing Participant Compensation Records for Compliance and Fairness” »

Compensation, Reimbursement & Undue Influence

Managing Tax, Benefits and Financial Reporting Implications of Study Payments

Posted on By digi

Managing Tax, Benefits and Financial Reporting Implications of Study Payments Managing Tax, Benefits and Financial Reporting Implications of Study Payments In the landscape of clinical research, understanding the tax implications, benefits, and financial reporting related to study payments is essential. This is particularly pertinent for professionals involved in world wide clinical trials, who must navigate…

Read More “Managing Tax, Benefits and Financial Reporting Implications of Study Payments” »

Compensation, Reimbursement & Undue Influence

Transparency Around Payments in Consent Forms and Recruitment Materials

Posted on By digi

Transparency Around Payments in Consent Forms and Recruitment Materials Transparency Around Payments in Consent Forms and Recruitment Materials In the evolving landscape of clinical research, transparency regarding financial compensation and reimbursements is essential for maintaining ethical standards and ensuring informed consent. This article provides a comprehensive guide regarding the ethical considerations surrounding payments in clinical…

Read More “Transparency Around Payments in Consent Forms and Recruitment Materials” »

Compensation, Reimbursement & Undue Influence

IRB/IEC Meeting Preparation: FAQs, Investigator Obligations and Documentation

Posted on By digi

IRB/IEC Meeting Preparation: FAQs, Investigator Obligations and Documentation IRB/IEC Meeting Preparation: FAQs, Investigator Obligations and Documentation Introduction to IRB/IEC Meetings In the realm of clinical trials, the Institutional Review Board (IRB) or Independent Ethics Committee (IEC) plays a pivotal role in safeguarding the rights and welfare of trial participants. As regulatory bodies, they ensure that…

Read More “IRB/IEC Meeting Preparation: FAQs, Investigator Obligations and Documentation” »

IRB/IEC Submission & Continuing Review

Central vs Local IRB Models: Operational Pros and Cons for Sponsors and CROs

Posted on By digi

Central vs Local IRB Models: Operational Pros and Cons for Sponsors and CROs In the field of clinical research, understanding the operational frameworks in which studies are conducted is essential for compliance with regulatory guidelines and ethical standards. One significant aspect of this is the choice between Central and Local Institutional Review Board (IRB) models….

Read More “Central vs Local IRB Models: Operational Pros and Cons for Sponsors and CROs” »

IRB/IEC Submission & Continuing Review

Sponsor Oversight of Site-Level IRB/IEC Compliance: Roles and Metrics

Posted on By digi

Sponsor Oversight of Site-Level IRB/IEC Compliance: Roles and Metrics Sponsor Oversight of Site-Level IRB/IEC Compliance: Roles and Metrics In the complex landscape of clinical research, ensuring that sites adhere to ethical standards monitored by Institutional Review Boards (IRBs) and Independent Ethics Committees (IECs) is paramount. This comprehensive guide provides a step-by-step approach for clinical operations,…

Read More “Sponsor Oversight of Site-Level IRB/IEC Compliance: Roles and Metrics” »

IRB/IEC Submission & Continuing Review

Continuing Review in High-Risk and Vulnerable Population Studies

Posted on By digi

Continuing Review in High-Risk and Vulnerable Population Studies Continuing review processes are crucial for maintaining ethical standards and regulatory compliance in clinical trials, especially when studies involve high-risk and vulnerable populations. The importance of systematic monitoring through methodologies such as remote monitoring in clinical trials is gaining traction, and this article aims to provide a…

Read More “Continuing Review in High-Risk and Vulnerable Population Studies” »

IRB/IEC Submission & Continuing Review

IRB/IEC Documentation for Inspection Readiness and TMF Quality

Posted on By digi

IRB/IEC Documentation for Inspection Readiness and TMF Quality Ensuring compliance and quality in clinical trials is a multifaceted process, critical for the integrity of data and the overall success of the trial. This article provides a comprehensive step-by-step guide for clinical operations, regulatory affairs, and medical affairs professionals focusing on Institutional Review Board (IRB) and…

Read More “IRB/IEC Documentation for Inspection Readiness and TMF Quality” »

IRB/IEC Submission & Continuing Review

What IRBs and IECs Look for in Risk–Benefit Justifications

Posted on By digi

What IRBs and IECs Look for in Risk–Benefit Justifications Understanding IRB and IEC Expectations for Risk–Benefit Justifications As clinical trials evolve in their complexity and methodology, the role of Institutional Review Boards (IRBs) and Independent Ethics Committees (IECs) has become increasingly critical in assessing the ethical validity of proposed research. For clinical operations, regulatory affairs,…

Read More “What IRBs and IECs Look for in Risk–Benefit Justifications” »

IRB/IEC Submission & Continuing Review